Dennis Roop
Concepts (837)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epidermis | 84 | 2024 | 157 | 8.540 |
Why?
| | Keratins | 113 | 2016 | 172 | 6.680 |
Why?
| | Keratinocytes | 56 | 2024 | 249 | 4.190 |
Why?
| | Skin Neoplasms | 57 | 2024 | 862 | 3.870 |
Why?
| | Membrane Proteins | 39 | 2022 | 1183 | 3.540 |
Why?
| | Skin | 53 | 2024 | 760 | 3.170 |
Why?
| | Trans-Activators | 26 | 2013 | 398 | 2.810 |
Why?
| | Papilloma | 31 | 2011 | 51 | 2.040 |
Why?
| | Cell Transformation, Neoplastic | 25 | 2016 | 342 | 2.030 |
Why?
| | Phosphoproteins | 17 | 2013 | 348 | 2.020 |
Why?
| | Cell Differentiation | 74 | 2024 | 2056 | 1.960 |
Why?
| | Hyperkeratosis, Epidermolytic | 17 | 2008 | 21 | 1.950 |
Why?
| | Mice, Transgenic | 66 | 2017 | 2185 | 1.890 |
Why?
| | NF-E2-Related Factor 2 | 7 | 2022 | 98 | 1.850 |
Why?
| | Stem Cells | 19 | 2017 | 623 | 1.820 |
Why?
| | Mice | 189 | 2024 | 18467 | 1.690 |
Why?
| | Genes, ras | 25 | 2012 | 96 | 1.510 |
Why?
| | Animals | 232 | 2024 | 38223 | 1.430 |
Why?
| | Hair Follicle | 14 | 2020 | 48 | 1.370 |
Why?
| | Vitiligo | 8 | 2024 | 42 | 1.220 |
Why?
| | Genetic Therapy | 12 | 2014 | 323 | 1.210 |
Why?
| | Melanocytes | 8 | 2024 | 64 | 1.090 |
Why?
| | Mutation | 37 | 2024 | 4120 | 1.090 |
Why?
| | Point Mutation | 13 | 2009 | 245 | 1.070 |
Why?
| | Skin Diseases | 8 | 2014 | 150 | 1.020 |
Why?
| | Carcinoma, Squamous Cell | 20 | 2016 | 647 | 1.000 |
Why?
| | Induced Pluripotent Stem Cells | 6 | 2024 | 276 | 0.990 |
Why?
| | Transforming Growth Factor alpha | 10 | 2000 | 56 | 0.910 |
Why?
| | Collagen Type VII | 2 | 2024 | 28 | 0.900 |
Why?
| | Cell Division | 20 | 2016 | 780 | 0.900 |
Why?
| | Ichthyosis | 7 | 2016 | 15 | 0.890 |
Why?
| | Epidermolysis Bullosa Dystrophica | 2 | 2024 | 42 | 0.880 |
Why?
| | Mice, Knockout | 35 | 2018 | 3124 | 0.880 |
Why?
| | Disease Models, Animal | 31 | 2020 | 4577 | 0.870 |
Why?
| | Phenotype | 28 | 2021 | 3185 | 0.830 |
Why?
| | Gene Expression Regulation | 31 | 2016 | 2630 | 0.830 |
Why?
| | Ectodermal Dysplasia | 5 | 2009 | 19 | 0.830 |
Why?
| | Cornified Envelope Proline-Rich Proteins | 7 | 2018 | 9 | 0.820 |
Why?
| | Morphogenesis | 7 | 2010 | 173 | 0.810 |
Why?
| | Base Sequence | 49 | 2016 | 2188 | 0.810 |
Why?
| | Melanoma | 10 | 2020 | 809 | 0.800 |
Why?
| | Gene Expression Regulation, Developmental | 14 | 2015 | 907 | 0.790 |
Why?
| | Ultraviolet Rays | 9 | 2024 | 388 | 0.790 |
Why?
| | DNA-Binding Proteins | 15 | 2015 | 1493 | 0.790 |
Why?
| | Genes, fos | 10 | 2000 | 37 | 0.770 |
Why?
| | Neoplasms, Experimental | 4 | 2019 | 172 | 0.760 |
Why?
| | Genes, p53 | 10 | 2012 | 67 | 0.750 |
Why?
| | Transgenes | 13 | 2016 | 188 | 0.750 |
Why?
| | Tetradecanoylphorbol Acetate | 21 | 2010 | 153 | 0.740 |
Why?
| | Tumor Suppressor Proteins | 8 | 2009 | 324 | 0.730 |
Why?
| | Proto-Oncogene Proteins c-myc | 6 | 2010 | 170 | 0.710 |
Why?
| | Tumor Suppressor Protein p53 | 6 | 2011 | 541 | 0.700 |
Why?
| | Skin Pigmentation | 4 | 2024 | 48 | 0.700 |
Why?
| | Cells, Cultured | 39 | 2024 | 4172 | 0.700 |
Why?
| | Intermediate Filament Proteins | 22 | 2012 | 57 | 0.700 |
Why?
| | Jews | 1 | 2021 | 19 | 0.690 |
Why?
| | Gene Expression Regulation, Neoplastic | 18 | 2015 | 1496 | 0.690 |
Why?
| | Skin Physiological Phenomena | 7 | 2008 | 24 | 0.680 |
Why?
| | Neoplastic Stem Cells | 7 | 2016 | 412 | 0.640 |
Why?
| | Cell Lineage | 5 | 2010 | 376 | 0.630 |
Why?
| | Ichthyosis, Lamellar | 2 | 2016 | 9 | 0.610 |
Why?
| | Cytoskeletal Proteins | 9 | 2012 | 156 | 0.610 |
Why?
| | Intravital Microscopy | 1 | 2019 | 25 | 0.610 |
Why?
| | Transcription Factors | 16 | 2015 | 1739 | 0.600 |
Why?
| | Molecular Sequence Data | 34 | 2012 | 2914 | 0.590 |
Why?
| | Genes, myc | 4 | 2011 | 52 | 0.590 |
Why?
| | Pluripotent Stem Cells | 2 | 2010 | 84 | 0.550 |
Why?
| | Hair | 6 | 2012 | 89 | 0.540 |
Why?
| | Signal Transduction | 22 | 2020 | 5256 | 0.540 |
Why?
| | Hedgehog Proteins | 7 | 2017 | 197 | 0.540 |
Why?
| | Genes | 15 | 2008 | 226 | 0.530 |
Why?
| | Immunity, Cellular | 1 | 2019 | 273 | 0.530 |
Why?
| | Skin Diseases, Genetic | 6 | 2020 | 13 | 0.530 |
Why?
| | Keratin-6 | 5 | 2016 | 6 | 0.510 |
Why?
| | Mice, Mutant Strains | 14 | 2016 | 306 | 0.510 |
Why?
| | Promoter Regions, Genetic | 17 | 2016 | 1256 | 0.490 |
Why?
| | Multipotent Stem Cells | 3 | 2010 | 21 | 0.480 |
Why?
| | Amino Acid Sequence | 30 | 2012 | 2148 | 0.480 |
Why?
| | Protein Isoforms | 8 | 2008 | 403 | 0.480 |
Why?
| | Head and Neck Neoplasms | 5 | 2016 | 560 | 0.470 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2016 | 119 | 0.470 |
Why?
| | Ultraviolet Therapy | 4 | 2024 | 17 | 0.460 |
Why?
| | Humans | 132 | 2024 | 144221 | 0.460 |
Why?
| | Keratoderma, Palmoplantar | 3 | 2014 | 6 | 0.460 |
Why?
| | Cell Proliferation | 14 | 2024 | 2541 | 0.450 |
Why?
| | Transforming Growth Factor beta | 8 | 2009 | 481 | 0.450 |
Why?
| | Pachyonychia Congenita | 3 | 2014 | 4 | 0.450 |
Why?
| | Viral Proteins | 4 | 2002 | 365 | 0.440 |
Why?
| | Genetic Vectors | 7 | 2013 | 343 | 0.430 |
Why?
| | Tretinoin | 11 | 2014 | 124 | 0.430 |
Why?
| | Gene Deletion | 8 | 2012 | 388 | 0.430 |
Why?
| | Keratosis | 7 | 2000 | 16 | 0.420 |
Why?
| | Epithelium | 14 | 2004 | 316 | 0.420 |
Why?
| | Animals, Newborn | 23 | 2007 | 902 | 0.420 |
Why?
| | DNA | 24 | 2018 | 1430 | 0.420 |
Why?
| | Cadherins | 3 | 2016 | 201 | 0.410 |
Why?
| | Cell Culture Techniques | 3 | 2014 | 380 | 0.410 |
Why?
| | Mice, Inbred ICR | 10 | 2011 | 113 | 0.410 |
Why?
| | Genes, Dominant | 6 | 2016 | 100 | 0.400 |
Why?
| | Cell Cycle | 3 | 2012 | 632 | 0.400 |
Why?
| | Amniotic Fluid | 2 | 2012 | 79 | 0.400 |
Why?
| | Mosaicism | 5 | 2014 | 75 | 0.390 |
Why?
| | Nails, Malformed | 2 | 2005 | 7 | 0.380 |
Why?
| | Up-Regulation | 8 | 2020 | 863 | 0.380 |
Why?
| | Abnormalities, Multiple | 3 | 2014 | 196 | 0.380 |
Why?
| | Eyelids | 2 | 2009 | 42 | 0.370 |
Why?
| | Keratin-10 | 8 | 2016 | 8 | 0.370 |
Why?
| | 9,10-Dimethyl-1,2-benzanthracene | 17 | 2010 | 25 | 0.370 |
Why?
| | Proteomics | 2 | 2016 | 1194 | 0.370 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2012 | 35 | 0.370 |
Why?
| | Melanoma, Experimental | 3 | 1998 | 112 | 0.370 |
Why?
| | Wnt Signaling Pathway | 2 | 2024 | 212 | 0.370 |
Why?
| | DNA Primers | 13 | 2010 | 517 | 0.370 |
Why?
| | Transcription, Genetic | 23 | 2017 | 1505 | 0.360 |
Why?
| | Cleft Lip | 2 | 2009 | 62 | 0.360 |
Why?
| | Carcinogens | 12 | 2010 | 123 | 0.360 |
Why?
| | Adaptor Proteins, Signal Transducing | 3 | 2012 | 439 | 0.360 |
Why?
| | Cleft Palate | 2 | 2009 | 82 | 0.350 |
Why?
| | Oncogene Proteins v-fos | 6 | 1999 | 11 | 0.350 |
Why?
| | Mutation, Missense | 3 | 2016 | 342 | 0.350 |
Why?
| | Apoptosis | 9 | 2012 | 2450 | 0.350 |
Why?
| | Gene Transfer Techniques | 4 | 2002 | 185 | 0.350 |
Why?
| | Wound Healing | 6 | 2010 | 361 | 0.340 |
Why?
| | Calcium | 12 | 2010 | 1183 | 0.340 |
Why?
| | Hyperplasia | 12 | 2002 | 174 | 0.330 |
Why?
| | Centrosome | 4 | 2012 | 71 | 0.330 |
Why?
| | Proteins | 3 | 2016 | 1028 | 0.330 |
Why?
| | Pedigree | 11 | 2000 | 513 | 0.330 |
Why?
| | Integrases | 5 | 2004 | 122 | 0.320 |
Why?
| | Alleles | 7 | 2016 | 883 | 0.310 |
Why?
| | RNA, Messenger | 35 | 2016 | 2859 | 0.310 |
Why?
| | Stem Cell Niche | 1 | 2010 | 58 | 0.310 |
Why?
| | Gene Targeting | 5 | 2008 | 83 | 0.310 |
Why?
| | Epidermolysis Bullosa Simplex | 4 | 2004 | 10 | 0.310 |
Why?
| | Transcription Factor AP-2 | 2 | 2008 | 82 | 0.300 |
Why?
| | Genes, Recessive | 2 | 2021 | 78 | 0.290 |
Why?
| | Mice, Nude | 12 | 2016 | 692 | 0.290 |
Why?
| | Immunotherapy | 3 | 2020 | 670 | 0.290 |
Why?
| | Female | 74 | 2024 | 77792 | 0.280 |
Why?
| | Polymerase Chain Reaction | 13 | 2002 | 1058 | 0.280 |
Why?
| | Mice, Inbred Strains | 13 | 2010 | 399 | 0.270 |
Why?
| | Keratins, Type II | 1 | 2007 | 2 | 0.270 |
Why?
| | Adenoviridae | 3 | 1998 | 203 | 0.270 |
Why?
| | Fluorescent Antibody Technique | 19 | 2004 | 376 | 0.260 |
Why?
| | Aurora Kinases | 3 | 2012 | 27 | 0.260 |
Why?
| | Lipid Metabolism | 5 | 2018 | 524 | 0.260 |
Why?
| | Octamer Transcription Factor-3 | 1 | 2007 | 19 | 0.260 |
Why?
| | Aurora Kinase A | 3 | 2012 | 62 | 0.250 |
Why?
| | Keratin-14 | 6 | 2012 | 15 | 0.250 |
Why?
| | Disease Progression | 6 | 2019 | 2874 | 0.250 |
Why?
| | Transcription Factor AP-1 | 3 | 2014 | 79 | 0.250 |
Why?
| | Mice, Inbred BALB C | 17 | 2020 | 1270 | 0.250 |
Why?
| | Mifepristone | 9 | 2009 | 64 | 0.250 |
Why?
| | Amino Acid Substitution | 4 | 2000 | 304 | 0.240 |
Why?
| | Skin Transplantation | 6 | 2024 | 86 | 0.240 |
Why?
| | Proto-Oncogenes | 1 | 2006 | 29 | 0.240 |
Why?
| | Ichthyosiform Erythroderma, Congenital | 2 | 2018 | 6 | 0.240 |
Why?
| | Genes, Reporter | 4 | 2009 | 275 | 0.240 |
Why?
| | Homeostasis | 3 | 2020 | 639 | 0.230 |
Why?
| | Models, Biological | 8 | 2016 | 1836 | 0.230 |
Why?
| | Kelch-Like ECH-Associated Protein 1 | 3 | 2016 | 12 | 0.230 |
Why?
| | Cell Line | 14 | 2018 | 2909 | 0.230 |
Why?
| | Oncogene Protein p21(ras) | 4 | 2004 | 15 | 0.230 |
Why?
| | Genomic Instability | 4 | 2011 | 68 | 0.230 |
Why?
| | Male | 50 | 2024 | 71752 | 0.230 |
Why?
| | Gene Expression | 12 | 2015 | 1514 | 0.220 |
Why?
| | Intermediate Filaments | 6 | 2015 | 26 | 0.220 |
Why?
| | Mouth Neoplasms | 2 | 2004 | 89 | 0.220 |
Why?
| | Keratin-1 | 2 | 2016 | 2 | 0.220 |
Why?
| | Skin Diseases, Vesiculobullous | 2 | 1999 | 18 | 0.220 |
Why?
| | Mice, Inbred C57BL | 19 | 2015 | 6042 | 0.220 |
Why?
| | Phosphodiesterase 4 Inhibitors | 1 | 2024 | 12 | 0.220 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 5 | 2015 | 267 | 0.220 |
Why?
| | Prenatal Diagnosis | 2 | 1998 | 194 | 0.210 |
Why?
| | Protein Precursors | 9 | 2006 | 135 | 0.210 |
Why?
| | Lipids | 4 | 2018 | 701 | 0.210 |
Why?
| | ras Proteins | 4 | 2013 | 155 | 0.210 |
Why?
| | beta Catenin | 3 | 2020 | 253 | 0.210 |
Why?
| | Retinoids | 2 | 1997 | 33 | 0.210 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2024 | 83 | 0.200 |
Why?
| | Heterozygote | 4 | 2010 | 315 | 0.200 |
Why?
| | Cocarcinogenesis | 4 | 2000 | 13 | 0.200 |
Why?
| | Sequence Analysis, DNA | 6 | 2016 | 828 | 0.200 |
Why?
| | Lac Operon | 2 | 2000 | 44 | 0.190 |
Why?
| | Proto-Oncogene Proteins | 5 | 2013 | 629 | 0.190 |
Why?
| | Transduction, Genetic | 4 | 2009 | 136 | 0.190 |
Why?
| | Transfection | 10 | 2017 | 952 | 0.190 |
Why?
| | Tongue | 2 | 2001 | 80 | 0.190 |
Why?
| | Antioxidants | 2 | 2020 | 581 | 0.190 |
Why?
| | Oncogenes | 5 | 1994 | 121 | 0.190 |
Why?
| | Cilia | 2 | 2017 | 173 | 0.190 |
Why?
| | Wnt Proteins | 3 | 2010 | 136 | 0.190 |
Why?
| | Cytoskeleton | 8 | 1994 | 197 | 0.190 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2010 | 992 | 0.190 |
Why?
| | Epithelial Cells | 14 | 2006 | 1128 | 0.180 |
Why?
| | Cell Membrane | 7 | 2015 | 709 | 0.180 |
Why?
| | Alopecia | 4 | 2005 | 37 | 0.180 |
Why?
| | Hindlimb | 2 | 1999 | 136 | 0.180 |
Why?
| | Micromanipulation | 1 | 2002 | 14 | 0.180 |
Why?
| | Human Growth Hormone | 1 | 2002 | 46 | 0.180 |
Why?
| | Chromosome Mapping | 5 | 2016 | 511 | 0.180 |
Why?
| | Chile | 1 | 2021 | 25 | 0.180 |
Why?
| | Colombia | 1 | 2021 | 42 | 0.180 |
Why?
| | Hair Diseases | 1 | 2001 | 10 | 0.180 |
Why?
| | Nail Diseases | 1 | 2001 | 9 | 0.170 |
Why?
| | Microscopy, Electron | 10 | 2002 | 415 | 0.170 |
Why?
| | Permeability | 3 | 2016 | 168 | 0.170 |
Why?
| | Blister | 1 | 2001 | 39 | 0.170 |
Why?
| | I-kappa B Kinase | 4 | 2009 | 51 | 0.170 |
Why?
| | Molecular Imprinting | 1 | 2020 | 5 | 0.170 |
Why?
| | Mexico | 1 | 2021 | 232 | 0.170 |
Why?
| | Neoplasm Transplantation | 6 | 2016 | 256 | 0.170 |
Why?
| | Microscopy, Confocal | 1 | 2002 | 324 | 0.160 |
Why?
| | Carcinoma | 5 | 1995 | 231 | 0.160 |
Why?
| | Ceramides | 3 | 2016 | 116 | 0.160 |
Why?
| | Cloning, Molecular | 9 | 2002 | 543 | 0.160 |
Why?
| | RNA | 6 | 2018 | 941 | 0.160 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2008 | 273 | 0.160 |
Why?
| | Regenerative Medicine | 2 | 2019 | 52 | 0.160 |
Why?
| | Adult Stem Cells | 1 | 2020 | 39 | 0.160 |
Why?
| | Laser Capture Microdissection | 2 | 2017 | 29 | 0.160 |
Why?
| | Blotting, Western | 8 | 2007 | 1207 | 0.160 |
Why?
| | Cell Membrane Permeability | 1 | 2020 | 85 | 0.160 |
Why?
| | Molecular Weight | 15 | 1990 | 325 | 0.150 |
Why?
| | Papillomaviridae | 3 | 2016 | 121 | 0.150 |
Why?
| | Genetic Linkage | 4 | 1999 | 274 | 0.150 |
Why?
| | Fibroblasts | 6 | 2024 | 1035 | 0.150 |
Why?
| | Bimatoprost | 1 | 2019 | 3 | 0.150 |
Why?
| | Immunologic Surveillance | 1 | 2019 | 26 | 0.150 |
Why?
| | Guided Tissue Regeneration | 1 | 2019 | 13 | 0.150 |
Why?
| | Precancerous Conditions | 4 | 2004 | 167 | 0.150 |
Why?
| | Crosses, Genetic | 4 | 2010 | 126 | 0.150 |
Why?
| | Antineoplastic Agents | 5 | 2016 | 2222 | 0.150 |
Why?
| | Zebrafish Proteins | 1 | 2002 | 311 | 0.150 |
Why?
| | Arginine | 2 | 2007 | 267 | 0.150 |
Why?
| | Deafness | 1 | 2000 | 78 | 0.150 |
Why?
| | Skin Aging | 2 | 1997 | 20 | 0.150 |
Why?
| | Alopecia Areata | 1 | 2019 | 13 | 0.150 |
Why?
| | Threonine | 1 | 1999 | 47 | 0.150 |
Why?
| | Asparagine | 1 | 1999 | 35 | 0.150 |
Why?
| | Thymidine Kinase | 2 | 1998 | 17 | 0.150 |
Why?
| | Zinc Finger Protein GLI1 | 2 | 2017 | 26 | 0.150 |
Why?
| | Janus Kinase Inhibitors | 1 | 2019 | 28 | 0.150 |
Why?
| | Caspase 14 | 1 | 2018 | 1 | 0.140 |
Why?
| | Ovalbumin | 7 | 1981 | 194 | 0.140 |
Why?
| | Tumor Cells, Cultured | 7 | 2016 | 944 | 0.140 |
Why?
| | Simplexvirus | 2 | 1998 | 82 | 0.140 |
Why?
| | Microscopy, Immunoelectron | 4 | 2016 | 45 | 0.140 |
Why?
| | Proto-Oncogene Proteins c-jun | 2 | 1999 | 55 | 0.140 |
Why?
| | Cytoprotection | 1 | 2018 | 55 | 0.140 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2020 | 947 | 0.140 |
Why?
| | Cellular Reprogramming Techniques | 1 | 2018 | 11 | 0.140 |
Why?
| | Transplantation, Heterologous | 3 | 2011 | 196 | 0.130 |
Why?
| | Autoimmunity | 1 | 2024 | 926 | 0.130 |
Why?
| | Caspase 3 | 2 | 2010 | 242 | 0.130 |
Why?
| | Potoroidae | 2 | 2007 | 3 | 0.130 |
Why?
| | Oncogene Proteins, Viral | 2 | 1994 | 22 | 0.130 |
Why?
| | Mammary Glands, Animal | 2 | 2006 | 131 | 0.130 |
Why?
| | Gene Silencing | 2 | 2016 | 204 | 0.130 |
Why?
| | Desmosomes | 2 | 2016 | 22 | 0.130 |
Why?
| | Receptors, Retinoic Acid | 1 | 1997 | 43 | 0.130 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 3 | 2013 | 238 | 0.130 |
Why?
| | Protein Multimerization | 1 | 2018 | 208 | 0.130 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 1997 | 57 | 0.130 |
Why?
| | Dermatitis, Atopic | 1 | 2020 | 330 | 0.130 |
Why?
| | Syndrome | 3 | 2009 | 373 | 0.130 |
Why?
| | Mutagenesis, Site-Directed | 4 | 1999 | 379 | 0.130 |
Why?
| | Neovascularization, Pathologic | 1 | 1998 | 290 | 0.130 |
Why?
| | Nucleic Acid Hybridization | 13 | 1991 | 189 | 0.120 |
Why?
| | Glucosylceramides | 1 | 2016 | 7 | 0.120 |
Why?
| | Phosphatidylinositol 3-Kinase | 1 | 2016 | 25 | 0.120 |
Why?
| | Kallikreins | 1 | 2016 | 24 | 0.120 |
Why?
| | Exons | 2 | 2016 | 358 | 0.120 |
Why?
| | Recombinant Fusion Proteins | 2 | 1996 | 685 | 0.120 |
Why?
| | Bone Morphogenetic Protein 4 | 2 | 2014 | 43 | 0.120 |
Why?
| | Side-Population Cells | 2 | 2013 | 8 | 0.120 |
Why?
| | Aldehyde Dehydrogenase | 2 | 2016 | 99 | 0.120 |
Why?
| | SOXB1 Transcription Factors | 1 | 2016 | 67 | 0.120 |
Why?
| | Gene Amplification | 2 | 2011 | 121 | 0.120 |
Why?
| | Microscopy, Fluorescence | 5 | 2007 | 423 | 0.120 |
Why?
| | Cell Movement | 5 | 2019 | 973 | 0.120 |
Why?
| | Epithelial-Mesenchymal Transition | 3 | 2013 | 224 | 0.120 |
Why?
| | Genes, Regulator | 2 | 1993 | 36 | 0.120 |
Why?
| | Amino Acid Motifs | 1 | 2016 | 225 | 0.120 |
Why?
| | Bromodeoxyuridine | 3 | 2001 | 80 | 0.120 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2016 | 149 | 0.120 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1999 | 406 | 0.110 |
Why?
| | Cetuximab | 1 | 2015 | 113 | 0.110 |
Why?
| | Hematopoietic Stem Cells | 3 | 2015 | 422 | 0.110 |
Why?
| | Receptors, Progesterone | 3 | 2002 | 353 | 0.110 |
Why?
| | Hand Deformities, Congenital | 1 | 2014 | 10 | 0.110 |
Why?
| | Chloracne | 1 | 2014 | 1 | 0.110 |
Why?
| | Trachea | 4 | 1993 | 256 | 0.110 |
Why?
| | Cricetinae | 9 | 1994 | 300 | 0.100 |
Why?
| | Keratin-2 | 3 | 2000 | 3 | 0.100 |
Why?
| | Dermis | 2 | 2010 | 32 | 0.100 |
Why?
| | RNA, Neoplasm | 6 | 1995 | 90 | 0.100 |
Why?
| | Genes, Tumor Suppressor | 2 | 2004 | 90 | 0.100 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2014 | 69 | 0.100 |
Why?
| | Cellular Reprogramming | 1 | 2014 | 103 | 0.100 |
Why?
| | Transcriptional Activation | 4 | 2007 | 382 | 0.100 |
Why?
| | Hormones | 2 | 1994 | 136 | 0.100 |
Why?
| | Recombination, Genetic | 2 | 2008 | 202 | 0.100 |
Why?
| | Embryonic and Fetal Development | 3 | 2002 | 91 | 0.100 |
Why?
| | Smad4 Protein | 1 | 2013 | 35 | 0.100 |
Why?
| | Genetic Engineering | 2 | 2007 | 99 | 0.100 |
Why?
| | DNA Mutational Analysis | 3 | 2018 | 408 | 0.100 |
Why?
| | Nuclear Proteins | 3 | 2006 | 751 | 0.100 |
Why?
| | Embryoid Bodies | 1 | 2013 | 8 | 0.100 |
Why?
| | Vagina | 3 | 1994 | 202 | 0.100 |
Why?
| | Fatty Acid Transport Proteins | 1 | 2012 | 19 | 0.100 |
Why?
| | DNA Restriction Enzymes | 7 | 1998 | 51 | 0.090 |
Why?
| | Keratins, Hair-Specific | 1 | 2012 | 1 | 0.090 |
Why?
| | RNA Splice Sites | 1 | 2012 | 50 | 0.090 |
Why?
| | Models, Animal | 4 | 2013 | 394 | 0.090 |
Why?
| | Polymorphism, Restriction Fragment Length | 3 | 2004 | 65 | 0.090 |
Why?
| | Polyploidy | 1 | 2012 | 15 | 0.090 |
Why?
| | Macromolecular Substances | 7 | 1992 | 224 | 0.090 |
Why?
| | Cell Separation | 2 | 2007 | 312 | 0.090 |
Why?
| | Quinone Reductases | 2 | 2002 | 17 | 0.090 |
Why?
| | Dermatology | 1 | 2014 | 128 | 0.090 |
Why?
| | Carrier Proteins | 2 | 2003 | 750 | 0.090 |
Why?
| | Immunohistochemistry | 14 | 2007 | 1734 | 0.090 |
Why?
| | Binding Sites | 4 | 2006 | 1313 | 0.090 |
Why?
| | RNA, Small Interfering | 3 | 2012 | 645 | 0.090 |
Why?
| | Embryo, Mammalian | 3 | 2010 | 234 | 0.090 |
Why?
| | Fetal Diseases | 1 | 1994 | 191 | 0.090 |
Why?
| | Cancer Vaccines | 3 | 1998 | 168 | 0.090 |
Why?
| | MicroRNAs | 2 | 2015 | 702 | 0.090 |
Why?
| | Cerebellar Ataxia | 1 | 2011 | 13 | 0.090 |
Why?
| | Immunocompetence | 1 | 2011 | 47 | 0.090 |
Why?
| | Regulatory Sequences, Nucleic Acid | 3 | 1999 | 97 | 0.080 |
Why?
| | Cell Count | 2 | 1991 | 324 | 0.080 |
Why?
| | Sebaceous Glands | 1 | 2010 | 5 | 0.080 |
Why?
| | Keratolytic Agents | 1 | 2010 | 5 | 0.080 |
Why?
| | Integrins | 1 | 2011 | 90 | 0.080 |
Why?
| | Epitopes | 3 | 1997 | 491 | 0.080 |
Why?
| | Introns | 4 | 2004 | 252 | 0.080 |
Why?
| | Decidua | 1 | 2010 | 23 | 0.080 |
Why?
| | Ribosomal Proteins | 1 | 2011 | 93 | 0.080 |
Why?
| | Calcification, Physiologic | 1 | 2011 | 37 | 0.080 |
Why?
| | Polymorphism, Genetic | 1 | 1993 | 618 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-fos | 3 | 1999 | 198 | 0.080 |
Why?
| | Nevus | 1 | 2010 | 26 | 0.080 |
Why?
| | Carcinogenesis | 3 | 2021 | 231 | 0.080 |
Why?
| | Tumor Microenvironment | 1 | 2015 | 739 | 0.080 |
Why?
| | Adenocarcinoma, Sebaceous | 1 | 2010 | 2 | 0.080 |
Why?
| | Sebaceous Gland Neoplasms | 1 | 2010 | 3 | 0.080 |
Why?
| | Genetic Techniques | 2 | 2005 | 68 | 0.080 |
Why?
| | Caspase 7 | 1 | 2010 | 22 | 0.080 |
Why?
| | Genotype | 4 | 2015 | 1839 | 0.080 |
Why?
| | In Situ Nick-End Labeling | 2 | 2007 | 123 | 0.080 |
Why?
| | Biomarkers, Tumor | 7 | 2009 | 1330 | 0.080 |
Why?
| | Aneuploidy | 2 | 2007 | 91 | 0.080 |
Why?
| | Osteoblasts | 1 | 2011 | 144 | 0.080 |
Why?
| | Arachidonate 12-Lipoxygenase | 1 | 2009 | 17 | 0.080 |
Why?
| | Organ Specificity | 4 | 2007 | 315 | 0.080 |
Why?
| | Liver Regeneration | 1 | 2010 | 47 | 0.080 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 1990 | 71 | 0.080 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2012 | 898 | 0.080 |
Why?
| | Teratoma | 1 | 2010 | 120 | 0.080 |
Why?
| | Disease Susceptibility | 5 | 2006 | 351 | 0.080 |
Why?
| | Oviducts | 9 | 1982 | 16 | 0.080 |
Why?
| | Uterus | 1 | 2010 | 229 | 0.070 |
Why?
| | Neoplasms | 2 | 2006 | 2914 | 0.070 |
Why?
| | Gene Expression Profiling | 4 | 2015 | 1826 | 0.070 |
Why?
| | Non-Fibrillar Collagens | 1 | 1988 | 3 | 0.070 |
Why?
| | Down-Regulation | 4 | 2009 | 641 | 0.070 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2015 | 1127 | 0.070 |
Why?
| | Pemphigoid, Bullous | 1 | 1988 | 7 | 0.070 |
Why?
| | Selection, Genetic | 1 | 2011 | 258 | 0.070 |
Why?
| | Muscle, Smooth | 1 | 1990 | 150 | 0.070 |
Why?
| | Collagen | 2 | 1988 | 467 | 0.070 |
Why?
| | Osteogenesis | 1 | 2011 | 206 | 0.070 |
Why?
| | Mitochondria | 1 | 2015 | 984 | 0.070 |
Why?
| | Receptor, Notch1 | 2 | 2006 | 64 | 0.070 |
Why?
| | Reactive Oxygen Species | 1 | 2012 | 646 | 0.070 |
Why?
| | Gene Knockdown Techniques | 1 | 2009 | 337 | 0.070 |
Why?
| | Spindle Apparatus | 1 | 2009 | 105 | 0.070 |
Why?
| | beta-Galactosidase | 2 | 1999 | 77 | 0.070 |
Why?
| | Stress, Physiological | 1 | 2012 | 455 | 0.070 |
Why?
| | Foot | 1 | 2009 | 102 | 0.070 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2005 | 115 | 0.070 |
Why?
| | Genes, Lethal | 2 | 2008 | 30 | 0.070 |
Why?
| | Hand | 1 | 2009 | 161 | 0.070 |
Why?
| | Olfactory Mucosa | 1 | 2008 | 39 | 0.070 |
Why?
| | Integrin beta1 | 2 | 2013 | 32 | 0.070 |
Why?
| | Hoof and Claw | 1 | 2007 | 9 | 0.070 |
Why?
| | Cell Death | 1 | 2009 | 388 | 0.070 |
Why?
| | Bone Marrow | 2 | 2015 | 303 | 0.070 |
Why?
| | Protein Structure, Tertiary | 2 | 2007 | 858 | 0.070 |
Why?
| | Langerhans Cells | 2 | 1997 | 12 | 0.070 |
Why?
| | Cytoplasmic Granules | 4 | 2002 | 74 | 0.070 |
Why?
| | Protein Conformation | 6 | 1992 | 937 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2010 | 467 | 0.070 |
Why?
| | Growth Substances | 2 | 1999 | 141 | 0.070 |
Why?
| | Caspase 9 | 1 | 2007 | 55 | 0.060 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1998 | 153 | 0.060 |
Why?
| | Species Specificity | 3 | 2000 | 573 | 0.060 |
Why?
| | Chloramphenicol O-Acetyltransferase | 2 | 1999 | 36 | 0.060 |
Why?
| | Adult | 10 | 2020 | 40228 | 0.060 |
Why?
| | Neoplasm Proteins | 2 | 2006 | 444 | 0.060 |
Why?
| | Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2006 | 19 | 0.060 |
Why?
| | Coculture Techniques | 2 | 2024 | 251 | 0.060 |
Why?
| | Cell Adhesion | 3 | 2015 | 457 | 0.060 |
Why?
| | Cell Line, Tumor | 5 | 2015 | 3619 | 0.060 |
Why?
| | Interleukin-1alpha | 2 | 2020 | 57 | 0.060 |
Why?
| | Microscopy, Fluorescence, Multiphoton | 1 | 2007 | 69 | 0.060 |
Why?
| | Ganciclovir | 2 | 1998 | 53 | 0.060 |
Why?
| | Twist-Related Protein 1 | 1 | 2006 | 9 | 0.060 |
Why?
| | Biological Assay | 1 | 2007 | 127 | 0.060 |
Why?
| | Blotting, Northern | 6 | 1992 | 202 | 0.060 |
Why?
| | Mice, SCID | 3 | 2013 | 377 | 0.060 |
Why?
| | Glycine | 1 | 2007 | 183 | 0.060 |
Why?
| | Lymphatic Metastasis | 1 | 2007 | 335 | 0.060 |
Why?
| | Phorbols | 1 | 1985 | 10 | 0.060 |
Why?
| | Darier Disease | 1 | 2005 | 2 | 0.060 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1950 | 0.060 |
Why?
| | Models, Genetic | 3 | 2008 | 535 | 0.060 |
Why?
| | Stomach | 2 | 2006 | 109 | 0.060 |
Why?
| | Autoantigens | 1 | 1988 | 432 | 0.060 |
Why?
| | Antibodies | 2 | 1985 | 402 | 0.060 |
Why?
| | Nucleic Acid Precursors | 3 | 1980 | 24 | 0.060 |
Why?
| | Protein Structure, Secondary | 2 | 1999 | 362 | 0.060 |
Why?
| | Enzyme Activation | 1 | 2007 | 782 | 0.060 |
Why?
| | Recombinant Proteins | 2 | 1999 | 1357 | 0.060 |
Why?
| | Flow Cytometry | 2 | 2007 | 1193 | 0.060 |
Why?
| | Cyclins | 2 | 1996 | 94 | 0.060 |
Why?
| | Cell Adhesion Molecules | 1 | 2006 | 178 | 0.060 |
Why?
| | Skin Abnormalities | 2 | 2002 | 12 | 0.060 |
Why?
| | Oxidative Stress | 1 | 2012 | 1377 | 0.060 |
Why?
| | Cell Cycle Proteins | 2 | 2006 | 636 | 0.050 |
Why?
| | Retinal Dehydrogenase | 2 | 2016 | 30 | 0.050 |
Why?
| | Nerve Tissue Proteins | 1 | 1988 | 600 | 0.050 |
Why?
| | Embryonic Development | 1 | 2005 | 126 | 0.050 |
Why?
| | Melanins | 1 | 2024 | 17 | 0.050 |
Why?
| | RNA Interference | 3 | 2013 | 482 | 0.050 |
Why?
| | Calcineurin | 1 | 2005 | 105 | 0.050 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 4 | 1990 | 331 | 0.050 |
Why?
| | Cyclopropanes | 1 | 2024 | 82 | 0.050 |
Why?
| | Sequence Analysis, RNA | 2 | 2017 | 452 | 0.050 |
Why?
| | Boron Compounds | 1 | 2024 | 29 | 0.050 |
Why?
| | Homeodomain Proteins | 2 | 2006 | 524 | 0.050 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2024 | 15 | 0.050 |
Why?
| | Transglutaminases | 3 | 1995 | 159 | 0.050 |
Why?
| | Blotting, Southern | 3 | 2001 | 85 | 0.050 |
Why?
| | In Vitro Techniques | 4 | 2013 | 1054 | 0.050 |
Why?
| | Aminopyridines | 1 | 2024 | 126 | 0.050 |
Why?
| | United States | 1 | 2021 | 15642 | 0.050 |
Why?
| | Receptors, Cell Surface | 2 | 2005 | 380 | 0.050 |
Why?
| | Benzamides | 1 | 2024 | 225 | 0.050 |
Why?
| | Pregnancy | 5 | 2010 | 7180 | 0.050 |
Why?
| | Tissue Distribution | 2 | 2002 | 328 | 0.050 |
Why?
| | Body Weight | 2 | 2011 | 993 | 0.050 |
Why?
| | Gene Editing | 1 | 2024 | 93 | 0.050 |
Why?
| | Transplantation, Autologous | 1 | 2024 | 292 | 0.050 |
Why?
| | Vimentin | 4 | 1994 | 54 | 0.050 |
Why?
| | Molecular Structure | 2 | 1994 | 499 | 0.050 |
Why?
| | Time Factors | 5 | 2004 | 7079 | 0.050 |
Why?
| | Vitamin K 3 | 1 | 2002 | 3 | 0.050 |
Why?
| | Biomarkers | 5 | 2004 | 4258 | 0.050 |
Why?
| | CRISPR-Cas Systems | 1 | 2024 | 170 | 0.050 |
Why?
| | Genetic Variation | 2 | 1998 | 990 | 0.050 |
Why?
| | S100 Proteins | 2 | 2000 | 36 | 0.050 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2024 | 274 | 0.050 |
Why?
| | Dacarbazine | 2 | 2012 | 99 | 0.050 |
Why?
| | Keratin-15 | 1 | 2002 | 17 | 0.050 |
Why?
| | Bioreactors | 1 | 2002 | 50 | 0.040 |
Why?
| | Keratin-5 | 1 | 2002 | 48 | 0.040 |
Why?
| | Immunoenzyme Techniques | 4 | 1993 | 201 | 0.040 |
Why?
| | Isomerism | 1 | 2001 | 55 | 0.040 |
Why?
| | Mesocricetus | 5 | 1993 | 46 | 0.040 |
Why?
| | 3T3 Cells | 3 | 2013 | 159 | 0.040 |
Why?
| | Vitamin A Deficiency | 3 | 1993 | 24 | 0.040 |
Why?
| | Starvation | 1 | 2001 | 23 | 0.040 |
Why?
| | Luteolytic Agents | 1 | 2001 | 1 | 0.040 |
Why?
| | Lasers | 1 | 2002 | 132 | 0.040 |
Why?
| | Mouth Diseases | 1 | 2001 | 46 | 0.040 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2004 | 435 | 0.040 |
Why?
| | Bone and Bones | 1 | 2004 | 322 | 0.040 |
Why?
| | Administration, Topical | 3 | 1997 | 152 | 0.040 |
Why?
| | Autoantibodies | 1 | 1988 | 1497 | 0.040 |
Why?
| | Response Elements | 2 | 2012 | 87 | 0.040 |
Why?
| | Benzo(a)pyrene | 1 | 2000 | 8 | 0.040 |
Why?
| | Nuclear Localization Signals | 1 | 2000 | 18 | 0.040 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2000 | 35 | 0.040 |
Why?
| | Frameshift Mutation | 1 | 2000 | 33 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2001 | 392 | 0.040 |
Why?
| | Dermatitis, Exfoliative | 1 | 2020 | 3 | 0.040 |
Why?
| | Netherton Syndrome | 1 | 2020 | 3 | 0.040 |
Why?
| | Cell Compartmentation | 1 | 2000 | 55 | 0.040 |
Why?
| | Cell Survival | 3 | 2013 | 1110 | 0.040 |
Why?
| | Adaptation, Biological | 1 | 2000 | 54 | 0.040 |
Why?
| | Immunoblotting | 4 | 2003 | 307 | 0.040 |
Why?
| | Potassium Channels, Voltage-Gated | 1 | 2020 | 54 | 0.040 |
Why?
| | Rats | 5 | 1994 | 5623 | 0.040 |
Why?
| | Chickens | 9 | 1995 | 192 | 0.040 |
Why?
| | rho GTP-Binding Proteins | 1 | 2020 | 56 | 0.040 |
Why?
| | Repressor Proteins | 2 | 2013 | 435 | 0.040 |
Why?
| | Zebrafish | 1 | 2004 | 526 | 0.040 |
Why?
| | Cell Nucleus | 7 | 2004 | 619 | 0.040 |
Why?
| | Estrenes | 1 | 1999 | 17 | 0.040 |
Why?
| | DNA, Complementary | 2 | 2003 | 278 | 0.040 |
Why?
| | DNA, Neoplasm | 3 | 1995 | 166 | 0.040 |
Why?
| | Kidney | 1 | 2007 | 1487 | 0.040 |
Why?
| | Restriction Mapping | 1 | 1999 | 81 | 0.040 |
Why?
| | Genomic Library | 1 | 1999 | 17 | 0.040 |
Why?
| | Genetic Carrier Screening | 1 | 1999 | 32 | 0.040 |
Why?
| | Phototherapy | 1 | 2019 | 48 | 0.040 |
Why?
| | Cell Self Renewal | 1 | 2019 | 53 | 0.040 |
Why?
| | Forelimb | 1 | 1999 | 39 | 0.040 |
Why?
| | Protein Transport | 1 | 2000 | 445 | 0.040 |
Why?
| | RNA, Heterogeneous Nuclear | 1 | 1978 | 6 | 0.040 |
Why?
| | Sequence Analysis | 1 | 1998 | 35 | 0.040 |
Why?
| | Reference Values | 3 | 2002 | 807 | 0.040 |
Why?
| | Dimerization | 1 | 1999 | 194 | 0.040 |
Why?
| | DNA Damage | 2 | 2012 | 433 | 0.040 |
Why?
| | Thrombospondin 1 | 1 | 1998 | 28 | 0.040 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 1998 | 79 | 0.040 |
Why?
| | Fungal Proteins | 1 | 1999 | 145 | 0.040 |
Why?
| | Endothelial Growth Factors | 1 | 1998 | 64 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2011 | 766 | 0.040 |
Why?
| | Lymphokines | 1 | 1998 | 130 | 0.040 |
Why?
| | Body Patterning | 1 | 1999 | 137 | 0.030 |
Why?
| | Peptides | 1 | 1984 | 992 | 0.030 |
Why?
| | Mutagenesis, Insertional | 1 | 1998 | 67 | 0.030 |
Why?
| | Genes, bcl-2 | 1 | 1998 | 22 | 0.030 |
Why?
| | Breast Neoplasms | 1 | 2011 | 2502 | 0.030 |
Why?
| | Neovascularization, Physiologic | 1 | 1999 | 197 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2002 | 1072 | 0.030 |
Why?
| | Age of Onset | 1 | 1999 | 543 | 0.030 |
Why?
| | Gamma Rays | 1 | 1998 | 58 | 0.030 |
Why?
| | Psoriasis | 2 | 1996 | 110 | 0.030 |
Why?
| | Antigens, Neoplasm | 2 | 1997 | 329 | 0.030 |
Why?
| | Retinoic Acid Receptor alpha | 1 | 1997 | 16 | 0.030 |
Why?
| | Thymus Gland | 1 | 1998 | 317 | 0.030 |
Why?
| | Epidermal Growth Factor | 3 | 1993 | 172 | 0.030 |
Why?
| | Retinoid X Receptors | 1 | 1997 | 38 | 0.030 |
Why?
| | Oxazines | 1 | 1997 | 36 | 0.030 |
Why?
| | Mitotic Index | 1 | 1997 | 25 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2006 | 2413 | 0.030 |
Why?
| | Protein Binding | 3 | 2009 | 2269 | 0.030 |
Why?
| | Metaplasia | 3 | 1993 | 58 | 0.030 |
Why?
| | Receptors, Calcitriol | 1 | 1997 | 55 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 2000 | 871 | 0.030 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 1997 | 78 | 0.030 |
Why?
| | Clinical Trials, Phase I as Topic | 1 | 1997 | 52 | 0.030 |
Why?
| | Luciferases | 2 | 2009 | 153 | 0.030 |
Why?
| | Hybrid Cells | 2 | 1994 | 49 | 0.030 |
Why?
| | Carcinogenicity Tests | 2 | 1994 | 10 | 0.030 |
Why?
| | Interleukin-2 | 1 | 1998 | 447 | 0.030 |
Why?
| | Hypertrophy | 1 | 1997 | 131 | 0.030 |
Why?
| | Organ Culture Techniques | 4 | 1990 | 153 | 0.030 |
Why?
| | Repetitive Sequences, Nucleic Acid | 2 | 1987 | 116 | 0.030 |
Why?
| | Body Temperature | 1 | 1997 | 223 | 0.030 |
Why?
| | Hyaluronan Receptors | 1 | 2016 | 104 | 0.030 |
Why?
| | Rats, Inbred F344 | 2 | 1993 | 269 | 0.030 |
Why?
| | Extremities | 1 | 1997 | 141 | 0.030 |
Why?
| | Rabbits | 2 | 1996 | 657 | 0.030 |
Why?
| | Spheroids, Cellular | 1 | 2016 | 73 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 1998 | 560 | 0.030 |
Why?
| | Kinetics | 5 | 1994 | 1623 | 0.030 |
Why?
| | Phospholipids | 1 | 1997 | 211 | 0.030 |
Why?
| | Biopsy | 2 | 1997 | 1069 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 1998 | 704 | 0.030 |
Why?
| | Maximum Tolerated Dose | 1 | 2015 | 213 | 0.030 |
Why?
| | Fluorescent Dyes | 1 | 1997 | 329 | 0.030 |
Why?
| | PAX3 Transcription Factor | 1 | 2015 | 17 | 0.030 |
Why?
| | Paired Box Transcription Factors | 1 | 2015 | 43 | 0.030 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1995 | 157 | 0.030 |
Why?
| | Inhibins | 1 | 1995 | 42 | 0.030 |
Why?
| | Interleukins | 1 | 1997 | 252 | 0.030 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2015 | 66 | 0.030 |
Why?
| | Random Allocation | 1 | 2016 | 364 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 346 | 0.030 |
Why?
| | Cantharidin | 1 | 1994 | 1 | 0.030 |
Why?
| | Benzoates | 1 | 1995 | 49 | 0.030 |
Why?
| | Tetrahydronaphthalenes | 1 | 1995 | 31 | 0.030 |
Why?
| | Ainhum | 1 | 2014 | 1 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2015 | 72 | 0.030 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 1997 | 219 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 1998 | 1266 | 0.030 |
Why?
| | DNA Probes, HPV | 1 | 1994 | 1 | 0.030 |
Why?
| | Evaluation Studies as Topic | 1 | 1994 | 169 | 0.030 |
Why?
| | Sequence Alignment | 1 | 1995 | 362 | 0.030 |
Why?
| | Actin Cytoskeleton | 1 | 1995 | 105 | 0.030 |
Why?
| | Staining and Labeling | 2 | 2010 | 149 | 0.030 |
Why?
| | Ornithine Decarboxylase | 1 | 1994 | 13 | 0.030 |
Why?
| | Epigen | 1 | 2014 | 1 | 0.030 |
Why?
| | Secretory Leukocyte Peptidase Inhibitor | 1 | 2014 | 6 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 854 | 0.030 |
Why?
| | Simian virus 40 | 1 | 1993 | 24 | 0.030 |
Why?
| | TATA Box | 1 | 1993 | 22 | 0.030 |
Why?
| | Collagen Type IV | 1 | 2014 | 28 | 0.030 |
Why?
| | Chorionic Villi | 1 | 1994 | 25 | 0.030 |
Why?
| | Open Reading Frames | 1 | 1994 | 133 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2015 | 769 | 0.030 |
Why?
| | Laminin | 1 | 1994 | 72 | 0.030 |
Why?
| | alpha Catenin | 1 | 2013 | 11 | 0.030 |
Why?
| | Lung Neoplasms | 1 | 2007 | 2640 | 0.030 |
Why?
| | Butylhydroxybutylnitrosamine | 1 | 1993 | 5 | 0.030 |
Why?
| | Multigene Family | 1 | 1994 | 204 | 0.030 |
Why?
| | Cholecalciferol | 1 | 1994 | 61 | 0.030 |
Why?
| | Clone Cells | 2 | 2010 | 269 | 0.030 |
Why?
| | Cell Dedifferentiation | 1 | 2013 | 32 | 0.030 |
Why?
| | Inhibitor of Apoptosis Proteins | 1 | 2013 | 47 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 2014 | 246 | 0.030 |
Why?
| | Mice, Inbred CBA | 1 | 2013 | 58 | 0.020 |
Why?
| | Middle Aged | 5 | 2020 | 35730 | 0.020 |
Why?
| | Ovariectomy | 1 | 1994 | 162 | 0.020 |
Why?
| | Sulfur Radioisotopes | 2 | 1990 | 13 | 0.020 |
Why?
| | Antigens, CD | 1 | 2016 | 564 | 0.020 |
Why?
| | Infant, Newborn | 2 | 2009 | 6380 | 0.020 |
Why?
| | DNA Probes | 2 | 1992 | 57 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2020 | 11501 | 0.020 |
Why?
| | Diseases in Twins | 1 | 1994 | 116 | 0.020 |
Why?
| | ErbB Receptors | 1 | 2016 | 627 | 0.020 |
Why?
| | Collagen Type I | 1 | 2014 | 143 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2013 | 194 | 0.020 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2016 | 453 | 0.020 |
Why?
| | Glycoproteins | 1 | 1995 | 357 | 0.020 |
Why?
| | Chromosomes, Mammalian | 1 | 2012 | 28 | 0.020 |
Why?
| | Lentivirus | 1 | 2013 | 61 | 0.020 |
Why?
| | Protein Biosynthesis | 6 | 1991 | 458 | 0.020 |
Why?
| | Forecasting | 1 | 1994 | 390 | 0.020 |
Why?
| | Aldehyde Oxidoreductases | 1 | 2012 | 28 | 0.020 |
Why?
| | Breast | 1 | 1993 | 162 | 0.020 |
Why?
| | Child | 3 | 2020 | 22491 | 0.020 |
Why?
| | Egg Proteins | 3 | 1982 | 20 | 0.020 |
Why?
| | Serine | 1 | 1993 | 138 | 0.020 |
Why?
| | Viruses | 1 | 1994 | 165 | 0.020 |
Why?
| | Bacteriophage lambda | 1 | 1993 | 89 | 0.020 |
Why?
| | Limb Buds | 2 | 2004 | 23 | 0.020 |
Why?
| | Coloring Agents | 1 | 2012 | 93 | 0.020 |
Why?
| | Cysteine | 1 | 1993 | 210 | 0.020 |
Why?
| | Isoenzymes | 1 | 2012 | 299 | 0.020 |
Why?
| | Tritium | 3 | 1994 | 68 | 0.020 |
Why?
| | Myoepithelioma | 1 | 1991 | 3 | 0.020 |
Why?
| | Mutagenicity Tests | 1 | 2011 | 16 | 0.020 |
Why?
| | Gene Knock-In Techniques | 1 | 2011 | 60 | 0.020 |
Why?
| | Avian Leukosis Virus | 1 | 2011 | 6 | 0.020 |
Why?
| | Age Factors | 2 | 1996 | 3294 | 0.020 |
Why?
| | Integrin-Binding Sialoprotein | 1 | 2011 | 5 | 0.020 |
Why?
| | Rodent Diseases | 1 | 1991 | 28 | 0.020 |
Why?
| | Ovomucin | 2 | 1982 | 9 | 0.020 |
Why?
| | Moloney murine leukemia virus | 1 | 1991 | 13 | 0.020 |
Why?
| | Haploinsufficiency | 1 | 2011 | 57 | 0.020 |
Why?
| | Biological Evolution | 2 | 1985 | 489 | 0.020 |
Why?
| | Hyperpigmentation | 1 | 2011 | 27 | 0.020 |
Why?
| | Interleukin-8 | 1 | 2012 | 273 | 0.020 |
Why?
| | Osteocalcin | 1 | 2011 | 38 | 0.020 |
Why?
| | Progesterone | 2 | 2010 | 256 | 0.020 |
Why?
| | Paclitaxel | 1 | 2012 | 256 | 0.020 |
Why?
| | Proteome | 1 | 2015 | 511 | 0.020 |
Why?
| | Growth Disorders | 1 | 2011 | 86 | 0.020 |
Why?
| | Wnt4 Protein | 1 | 2010 | 20 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1986 | 0.020 |
Why?
| | Immunosorbent Techniques | 2 | 1987 | 18 | 0.020 |
Why?
| | Embryo Implantation | 1 | 2010 | 31 | 0.020 |
Why?
| | Infant | 2 | 2009 | 9911 | 0.020 |
Why?
| | Mice, Inbred NOD | 1 | 2012 | 618 | 0.020 |
Why?
| | Cytokines | 2 | 2015 | 2098 | 0.020 |
Why?
| | Swine | 1 | 1993 | 843 | 0.020 |
Why?
| | Pigmentation | 1 | 2010 | 53 | 0.020 |
Why?
| | Urinary Bladder Neoplasms | 1 | 1993 | 252 | 0.020 |
Why?
| | Mitosis | 1 | 2011 | 202 | 0.020 |
Why?
| | Estrogens | 4 | 1982 | 377 | 0.020 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 1997 | 948 | 0.020 |
Why?
| | Phospholipases A2 | 1 | 2010 | 82 | 0.020 |
Why?
| | Mouth Mucosa | 1 | 1990 | 89 | 0.020 |
Why?
| | Animals, Wild | 1 | 1990 | 61 | 0.020 |
Why?
| | Adenoma, Pleomorphic | 1 | 1990 | 9 | 0.020 |
Why?
| | Parotid Neoplasms | 1 | 1990 | 14 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 1994 | 1503 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1858 | 0.020 |
Why?
| | Smad3 Protein | 1 | 2009 | 43 | 0.020 |
Why?
| | Enzyme Induction | 1 | 2009 | 87 | 0.020 |
Why?
| | Arachidonic Acid | 1 | 2010 | 107 | 0.020 |
Why?
| | Mice, Inbred C3H | 1 | 1990 | 251 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 1998 | 2045 | 0.020 |
Why?
| | Child, Preschool | 2 | 2009 | 11656 | 0.020 |
Why?
| | Liver | 2 | 2002 | 1848 | 0.020 |
Why?
| | Transcriptome | 1 | 2016 | 1049 | 0.020 |
Why?
| | Anemia | 1 | 2011 | 180 | 0.020 |
Why?
| | DNA Repair | 1 | 2012 | 255 | 0.020 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2009 | 85 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2009 | 140 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 1999 | 5326 | 0.020 |
Why?
| | Amino Acids | 4 | 2002 | 519 | 0.020 |
Why?
| | Dinoprostone | 1 | 2010 | 180 | 0.020 |
Why?
| | Imidazoles | 1 | 2010 | 255 | 0.020 |
Why?
| | Diethylstilbestrol | 2 | 1979 | 9 | 0.020 |
Why?
| | Dystonin | 1 | 1988 | 1 | 0.020 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2010 | 196 | 0.020 |
Why?
| | Ameloblastoma | 1 | 1988 | 5 | 0.020 |
Why?
| | Methionine | 1 | 1989 | 163 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3618 | 0.020 |
Why?
| | Lactation | 1 | 1990 | 193 | 0.020 |
Why?
| | Cell Communication | 1 | 2010 | 326 | 0.020 |
Why?
| | Tissue Scaffolds | 1 | 2011 | 222 | 0.020 |
Why?
| | gamma-Glutamyltransferase | 1 | 1988 | 37 | 0.020 |
Why?
| | Vitamin A | 2 | 1986 | 56 | 0.020 |
Why?
| | Cellular Senescence | 1 | 2010 | 229 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2009 | 516 | 0.020 |
Why?
| | Isoelectric Point | 1 | 1987 | 23 | 0.020 |
Why?
| | Piperazines | 1 | 2010 | 394 | 0.020 |
Why?
| | Antigens, Differentiation | 1 | 1988 | 78 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 858 | 0.020 |
Why?
| | Survival Analysis | 1 | 2010 | 1361 | 0.020 |
Why?
| | Protease Inhibitors | 1 | 1988 | 103 | 0.020 |
Why?
| | Interferon-gamma | 1 | 1990 | 792 | 0.020 |
Why?
| | Antigens, Ly | 1 | 1987 | 41 | 0.020 |
Why?
| | Harvey murine sarcoma virus | 1 | 1986 | 1 | 0.020 |
Why?
| | Dimethyl Sulfoxide | 1 | 1987 | 40 | 0.020 |
Why?
| | Occludin | 1 | 2006 | 12 | 0.020 |
Why?
| | Organoids | 1 | 1988 | 140 | 0.020 |
Why?
| | LIM Domain Proteins | 1 | 2006 | 21 | 0.020 |
Why?
| | Claudin-1 | 1 | 2006 | 15 | 0.020 |
Why?
| | Olfactory Bulb | 1 | 2008 | 98 | 0.020 |
Why?
| | Minichromosome Maintenance Complex Component 7 | 1 | 2006 | 6 | 0.020 |
Why?
| | Interleukin-6 | 1 | 1990 | 791 | 0.020 |
Why?
| | Immunoassay | 1 | 1987 | 113 | 0.020 |
Why?
| | Receptors, Steroid | 1 | 2006 | 46 | 0.020 |
Why?
| | Chemistry | 1 | 1985 | 41 | 0.010 |
Why?
| | Chemical Phenomena | 1 | 1985 | 80 | 0.010 |
Why?
| | Fluocinolone Acetonide | 1 | 1985 | 15 | 0.010 |
Why?
| | X-Ray Diffraction | 1 | 1985 | 104 | 0.010 |
Why?
| | Calcium-Binding Proteins | 1 | 1986 | 220 | 0.010 |
Why?
| | Phosphorylation | 1 | 2009 | 1761 | 0.010 |
Why?
| | Microscopy, Electron, Scanning | 1 | 1985 | 202 | 0.010 |
Why?
| | HeLa Cells | 1 | 2007 | 654 | 0.010 |
Why?
| | Erythroid-Specific DNA-Binding Factors | 1 | 2004 | 15 | 0.010 |
Why?
| | Calcineurin Inhibitors | 1 | 2005 | 69 | 0.010 |
Why?
| | Cattle | 2 | 1988 | 1005 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2012 | 2178 | 0.010 |
Why?
| | YY1 Transcription Factor | 1 | 2004 | 23 | 0.010 |
Why?
| | NFATC Transcription Factors | 1 | 2005 | 93 | 0.010 |
Why?
| | Base Composition | 1 | 1984 | 79 | 0.010 |
Why?
| | Protein Processing, Post-Translational | 1 | 1987 | 478 | 0.010 |
Why?
| | Hormone Antagonists | 1 | 2004 | 34 | 0.010 |
Why?
| | Thymidine | 2 | 1994 | 59 | 0.010 |
Why?
| | Antigen-Antibody Complex | 1 | 1984 | 72 | 0.010 |
Why?
| | Fibroblast Growth Factor 8 | 1 | 2004 | 27 | 0.010 |
Why?
| | Interleukin-1 | 1 | 1988 | 962 | 0.010 |
Why?
| | Receptors, Fibroblast Growth Factor | 1 | 2004 | 69 | 0.010 |
Why?
| | Aged | 3 | 2020 | 25674 | 0.010 |
Why?
| | src-Family Kinases | 1 | 2004 | 99 | 0.010 |
Why?
| | Stomach Diseases | 1 | 2003 | 20 | 0.010 |
Why?
| | Weaning | 1 | 2003 | 42 | 0.010 |
Why?
| | Craniofacial Abnormalities | 1 | 2004 | 76 | 0.010 |
Why?
| | Esophageal Diseases | 1 | 2003 | 30 | 0.010 |
Why?
| | Young Adult | 1 | 2020 | 13949 | 0.010 |
Why?
| | Mice, Hairless | 2 | 1994 | 47 | 0.010 |
Why?
| | Antibodies, Monoclonal | 2 | 1990 | 1524 | 0.010 |
Why?
| | Terminology as Topic | 1 | 1985 | 255 | 0.010 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2003 | 78 | 0.010 |
Why?
| | Extracellular Matrix | 1 | 1987 | 564 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 2008 | 1048 | 0.010 |
Why?
| | Adolescent | 2 | 2020 | 22281 | 0.010 |
Why?
| | Fibroblast Growth Factors | 1 | 2004 | 188 | 0.010 |
Why?
| | Cheek | 2 | 1993 | 16 | 0.010 |
Why?
| | Aging | 1 | 1993 | 1972 | 0.010 |
Why?
| | Fertility | 1 | 2002 | 167 | 0.010 |
Why?
| | RNA, Small Nuclear | 1 | 1981 | 38 | 0.010 |
Why?
| | Mice, Inbred A | 1 | 2000 | 48 | 0.010 |
Why?
| | Biotransformation | 1 | 2000 | 62 | 0.010 |
Why?
| | Peptide Fragments | 1 | 1984 | 706 | 0.010 |
Why?
| | Sequence Homology | 1 | 1999 | 44 | 0.010 |
Why?
| | Risk Factors | 1 | 1994 | 10642 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2003 | 2032 | 0.010 |
Why?
| | Limb Deformities, Congenital | 1 | 1999 | 21 | 0.010 |
Why?
| | Neurons | 1 | 2008 | 1637 | 0.010 |
Why?
| | Phosphorus Radioisotopes | 1 | 1978 | 27 | 0.010 |
Why?
| | Globins | 1 | 1978 | 21 | 0.010 |
Why?
| | Reticulocytes | 1 | 1978 | 17 | 0.010 |
Why?
| | Polyribosomes | 1 | 1978 | 22 | 0.010 |
Why?
| | Cholera Toxin | 2 | 1988 | 30 | 0.010 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 1998 | 100 | 0.010 |
Why?
| | Antibody Specificity | 2 | 1989 | 185 | 0.010 |
Why?
| | DNA Fragmentation | 1 | 1998 | 41 | 0.010 |
Why?
| | Drug Stability | 1 | 1978 | 165 | 0.010 |
Why?
| | Isotope Labeling | 1 | 1978 | 82 | 0.010 |
Why?
| | RNA Polymerase II | 1 | 1981 | 349 | 0.010 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 1998 | 335 | 0.010 |
Why?
| | Immunologic Techniques | 2 | 1986 | 39 | 0.010 |
Why?
| | Desmogleins | 1 | 1996 | 3 | 0.010 |
Why?
| | T-Lymphocyte Subsets | 1 | 1998 | 422 | 0.010 |
Why?
| | Desmoplakins | 1 | 1996 | 27 | 0.010 |
Why?
| | Receptors, Estrogen | 1 | 1979 | 466 | 0.010 |
Why?
| | Follistatin | 1 | 1995 | 12 | 0.010 |
Why?
| | Vibrissae | 1 | 1995 | 11 | 0.010 |
Why?
| | Activins | 1 | 1995 | 29 | 0.010 |
Why?
| | Musculoskeletal Abnormalities | 1 | 1995 | 14 | 0.010 |
Why?
| | Xenopus | 1 | 1995 | 86 | 0.010 |
Why?
| | Palate | 1 | 1995 | 42 | 0.010 |
Why?
| | Musculoskeletal System | 1 | 1995 | 48 | 0.010 |
Why?
| | Estrus | 1 | 1994 | 16 | 0.010 |
Why?
| | Acetone | 1 | 1994 | 12 | 0.010 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 1998 | 727 | 0.010 |
Why?
| | Membrane Glycoproteins | 1 | 1997 | 499 | 0.010 |
Why?
| | Lymph Nodes | 1 | 1997 | 505 | 0.010 |
Why?
| | Skull | 1 | 1995 | 155 | 0.010 |
Why?
| | Cell Fusion | 1 | 1993 | 49 | 0.010 |
Why?
| | Dendritic Cells | 1 | 1997 | 497 | 0.010 |
Why?
| | Protein Kinase C | 1 | 1994 | 252 | 0.010 |
Why?
| | Organelles | 1 | 1991 | 59 | 0.010 |
Why?
| | Cell Line, Transformed | 1 | 1991 | 141 | 0.010 |
Why?
| | Retroviridae | 1 | 1991 | 104 | 0.010 |
Why?
| | Peptide Mapping | 1 | 1990 | 64 | 0.010 |
Why?
| | Trypsin | 1 | 1990 | 76 | 0.010 |
Why?
| | von Willebrand Factor | 1 | 1990 | 85 | 0.000 |
Why?
| | DNA, Recombinant | 2 | 1979 | 48 | 0.000 |
Why?
| | RNA Probes | 1 | 1988 | 14 | 0.000 |
Why?
| | Autoradiography | 1 | 1988 | 64 | 0.000 |
Why?
| | HLA-DR Antigens | 1 | 1990 | 219 | 0.000 |
Why?
| | Histocytochemistry | 1 | 1988 | 79 | 0.000 |
Why?
| | Metaphase | 1 | 1988 | 33 | 0.000 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 1988 | 50 | 0.000 |
Why?
| | Cytoplasm | 1 | 1988 | 270 | 0.000 |
Why?
| | Microbial Collagenase | 1 | 1987 | 9 | 0.000 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 1988 | 111 | 0.000 |
Why?
| | Culture Techniques | 1 | 1987 | 67 | 0.000 |
Why?
| | Cross Reactions | 1 | 1988 | 135 | 0.000 |
Why?
| | Light | 1 | 1990 | 411 | 0.000 |
Why?
| | Leukemia, Radiation-Induced | 1 | 1987 | 4 | 0.000 |
Why?
| | Proto-Oncogene Proteins c-sis | 1 | 1987 | 39 | 0.000 |
Why?
| | Leukemia, Experimental | 1 | 1987 | 28 | 0.000 |
Why?
| | Cricetulus | 1 | 1987 | 116 | 0.000 |
Why?
| | Diterpenes | 1 | 1986 | 26 | 0.000 |
Why?
| | Genetic Markers | 1 | 1987 | 338 | 0.000 |
Why?
| | Inflammation | 1 | 1997 | 2900 | 0.000 |
Why?
| | Lipopolysaccharides | 1 | 1988 | 873 | 0.000 |
Why?
| | Incidence | 1 | 1991 | 2852 | 0.000 |
Why?
| | Aged, 80 and over | 1 | 1996 | 8152 | 0.000 |
Why?
| | Poly A | 1 | 1982 | 50 | 0.000 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 1979 | 63 | 0.000 |
Why?
| | Retrospective Studies | 1 | 1991 | 16803 | 0.000 |
Why?
|
|
Roop's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|